BGNE BeiGene Ltd

Price (delayed)

$314.14

Market cap

$29.5B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.08

Enterprise value

$28.82B

Highlights

The company's EPS rose by 31% YoY and by 2.7% QoQ

BeiGene's gross margin has increased by 17% YoY

BeiGene's debt has soared by 187% YoY and by 2.8% from the previous quarter

BeiGene's quick ratio has shrunk by 58% YoY and by 14% QoQ

Sector: Healthcare

Industry: Biotechnology

Website: http://www.beigene.com/

Peers: ONTX OPK

Key stats

What are the main financial stats of BGNE

Market

Shares outstanding

93.92M

Market cap

$29.5B

Enterprise value

$28.82B

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

8.73

Price to sales (P/S)

27.46

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

27.13

Earnings

Revenue

$1.06B

EBIT

-$1.32B

EBITDA

-$1.28B

Free cash flow

-$1.31B

Per share

EPS

-$1.08

Free cash flow per share

-$14.06

Book value per share

$36

Revenue per share

$11.44

TBVPS

$56.78

Balance sheet

Total assets

$5.29B

Total liabilities

$1.93B

Debt

$699.54M

Equity

$3.36B

Working capital

$3.13B

Liquidity

Debt to equity

0.21

Current ratio

3.4

Quick ratio

3.1

Net debt/EBITDA

0.54

Margins

EBITDA margin

-120.1%

Gross margin

87.1%

Net margin

-122.4%

Operating margin

-127.2%

Efficiency

Return on assets

-23.4%

Return on equity

-35.1%

Return on invested capital

-38.8%

Return on capital employed

-33.1%

Return on sales

-124%

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

BGNE stock price

How has the BeiGene stock price performed over time

Intraday

-9.17%

1 week

-9.65%

1 month

-15.94%

1 year

41.95%

YTD

21.58%

QTD

-13.46%

Financial performance

How have BeiGene's revenue and profit performed over time

Revenue

$1.06B

Gross profit

$924.97M

Operating income

-$1.35B

Net income

-$1.3B

Gross margin

87.1%

Net margin

-122.4%

BeiGene's net margin has soared by 78% YoY and by 12% from the previous quarter

BGNE's operating margin has surged by 78% year-on-year and by 9% since the previous quarter

BeiGene's gross margin has increased by 17% YoY

The net income is up by 14% year-on-year

Growth

What is BeiGene's growth rate over time

Valuation

What is BeiGene stock price valuation

P/E

N/A

P/B

8.73

P/S

27.46

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

27.13

The company's EPS rose by 31% YoY and by 2.7% QoQ

The price to book (P/B) is 41% higher than the 5-year quarterly average of 6.2 and 6% higher than the last 4 quarters average of 8.2

The equity has contracted by 22% YoY and by 7% from the previous quarter

BGNE's price to sales (P/S) is 90% lower than its 5-year quarterly average of 275.2 and 36% lower than its last 4 quarters average of 43.0

The revenue has grown by 12% from the previous quarter

Efficiency

How efficient is BeiGene business performance

The company's return on sales has surged by 78% YoY and by 11% QoQ

BeiGene's ROIC has increased by 43% YoY but it has decreased by 2.9% from the previous quarter

The company's return on assets rose by 41% YoY

BGNE's return on equity is up by 39% year-on-year but it is down by 5% since the previous quarter

Dividends

What is BGNE's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for BGNE.

Financial health

How did BeiGene financials performed over time

The total assets is 174% greater than the total liabilities

BeiGene's quick ratio has shrunk by 58% YoY and by 14% QoQ

The current ratio has dropped by 56% year-on-year and by 12% since the previous quarter

BeiGene's debt is 79% less than its equity

BeiGene's debt has soared by 187% YoY and by 2.8% from the previous quarter

The equity has contracted by 22% YoY and by 7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.